Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial
Clinical trial NCT04721301 · COMPLETED
Trial details
- NCT number
- NCT04721301
- Sponsor
- University Hospital Heidelberg
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-15
- Primary completion
- 2023-03-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.